Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures

[1]  G van der Pluijm,et al.  The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation , 2012, Oncogene.

[2]  Yu‐Chi Wang,et al.  Tumorigenesis and Neoplastic Progression ALDH 1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD 44 Expression , Drug Resistance , and Poor Clinical Outcome , 2012 .

[3]  J. Visvader,et al.  Aldehyde Dehydrogenase Activity Is a Biomarker of Primitive Normal Human Mammary Luminal Cells , 2012, Stem cells.

[4]  Benjamin G. Bitler,et al.  ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches , 2011, Cancer Prevention Research.

[5]  E. Lander,et al.  Theory Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells , 2011 .

[6]  David E. Misek,et al.  Comprehensive Proteomic Profiling of Aldehyde Dehydrogenases in Lung Adenocarcinoma Cell Lines , 2011, International journal of proteomics.

[7]  V. Mazzaferro,et al.  Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma , 2011, PloS one.

[8]  G. van der Pluijm,et al.  The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis , 2011, Clinical & Experimental Metastasis.

[9]  P. Marcato,et al.  Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform , 2011, Cell cycle.

[10]  Brian C. Jackson,et al.  Update on the aldehyde dehydrogenase gene (ALDH) superfamily , 2011, Human Genomics.

[11]  Paul A. Wiggins,et al.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state , 2011, Proceedings of the National Academy of Sciences.

[12]  Patrick W. Lee,et al.  Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis , 2011, Stem cells.

[13]  J. Luborsky,et al.  Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors , 2010, Journal of ovarian research.

[14]  R. Bast,et al.  Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer , 2010, Molecular Cancer Therapeutics.

[15]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[16]  C. Brocker,et al.  Aldehyde Dehydrogenase 3B1 (ALDH3B1): Immunohistochemical Tissue Distribution and Cellular-specific Localization in Normal and Cancerous Human Tissues , 2010 .

[17]  F. Hamdy,et al.  High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. , 2010, Cancer research.

[18]  Lin Zhang,et al.  Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers , 2010, PloS one.

[19]  G. Castellano,et al.  Tumor initiating cells: Development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension , 2010, Cell cycle.

[20]  F. Bertucci,et al.  Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer , 2009, Clinical Cancer Research.

[21]  O. Witte,et al.  Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. , 2009, Cancer research.

[22]  D. Steindler,et al.  Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. , 2009, Cancer research.

[23]  F. Bertucci,et al.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.

[24]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[25]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[26]  C. D. Salcido,et al.  Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.

[27]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[28]  Vasilis Vasiliou,et al.  Multiple and Additive Functions of ALDH3A1 and ALDH1A1 , 2007, Journal of Biological Chemistry.

[29]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[30]  F. Nezhat,et al.  Endometriosis and the Relationship to Ovarian Cancer , 2006 .

[31]  R. Berkowitz,et al.  Selenium binding protein 1 in ovarian cancer , 2006, International journal of cancer.

[32]  W. McCluggage,et al.  Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features , 2005, Histopathology.

[33]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[34]  V. Vasiliou,et al.  Molecular cloning and baculovirus expression of the rabbit corneal aldehyde dehydrogenase (ALDH1A1) cDNA. , 2003, DNA and cell biology.

[35]  Mitsuaki Suzuki,et al.  Low Proliferation Activity May Be Associated With Chemoresistance in Clear Cell Carcinoma of the Ovary , 2002, Obstetrics and gynecology.

[36]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[37]  M. Piver,et al.  Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum‐based chemotherapy , 1996, Cancer.

[38]  J. Cain,et al.  Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. , 1996, Gynecologic oncology.

[39]  R. Kryscio,et al.  Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. , 1992, Gynecologic oncology.

[40]  P. Clement,et al.  Pathology of the fallopian tube, broad ligament, peritoneum, and pelvic soft tissues. , 1991, Human pathology.

[41]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[42]  D. Fortune.  Histological Typing of Ovarian Tumours , 1975 .

[43]  C. Brocker,et al.  Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues. , 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  S. Memarzadeh,et al.  Epithelial stem cells of the prostate and their role in cancer progression. , 2008, Cold Spring Harbor symposia on quantitative biology.

[45]  C. Brocker,et al.  Non-P 450 aldehyde oxidizing enzymes : the aldehyde dehydrogenase superfamily , 2009 .

[46]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[47]  R. Osborn.  Histological Typing of Ovarian Tumours. International Histology Classification of Tumours, S.F. Serov, R.E. Scully. World Health Organization, Geneva (1973), 56, Slides: £21.00, US$51.00, Book only: £6.65, US$16.50 , 1975 .